Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,125,160    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,064,010      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-09-02 4 AS $20.89 $20,890 D/D (1,000) 95,067 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-17 4 S $21.00 $210,000 D/D (10,000) 6,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-09-01 4 AS $21.00 $63,000 D/D (3,000) 96,067 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-07 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-08 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-16 4 OE $21.51 $21,510 D/D 1,000 326,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-09-27 4 OE $21.51 $21,510 D/D 1,000 327,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-10-25 4 OE $21.51 $107,550 D/D 5,000 332,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-22 4 OE $21.51 $215,100 D/D 10,000 337,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-26 4 OE $21.51 $64,530 D/D 3,000 330,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-27 4 OE $21.51 $107,550 D/D 5,000 332,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-07 4 OE $21.51 $64,530 D/D 3,000 330,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-08 4 OE $21.51 $86,040 D/D 4,000 331,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-14 4 OE $21.51 $172,080 D/D 8,000 335,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-30 4 OE $21.51 $21,510 D/D 1,000 328,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-02-03 4 OE $21.51 $215,100 D/D 10,000 338,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 OE $21.51 $215,100 D/D 10,000 306,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-09 4 OE $21.51 $215,100 D/D 10,000 308,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-27 4 OE $21.51 $430,200 D/D 20,000 318,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-28 4 OE $21.51 $430,200 D/D 20,000 318,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-01 4 OE $21.51 $86,040 D/D 4,000 302,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-04 4 OE $21.51 $107,550 D/D 5,000 303,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-08 4 OE $21.51 $430,200 D/D 20,000 318,552 0 -
PTLA Portola Pharmaceuticals I... Director   –       •      –    2014-05-16 4 S $22.03 $22,030 D/D (1,000) 706 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-09-08 4 S $22.22 $22,220 D/D (1,000) 95,067 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 15 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us